Cargando…

Strong correlation of lumefantrine concentrations in capillary and venous plasma from malaria patients

BACKGROUND: Lumefantrine is a long-acting antimalarial drug with an elimination half-life of over 3 days and protein binding of 99 percent. Correlation of lumefantrine concentrations from capillary plasma via fingerprick (C(c)) versus venous plasma (C(v)) remains to be defined. METHODS: Venous and c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Liusheng, Mwebaza, Norah, Kajubi, Richard, Marzan, Florence, Forsman, Camilla, Parikh, Sunil, Aweeka, Francesca T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095545/ https://www.ncbi.nlm.nih.gov/pubmed/30114201 http://dx.doi.org/10.1371/journal.pone.0202082

Ejemplares similares

Determination of piperaquine concentration in human plasma and the correlation of capillary versus venous plasma concentrations
por: Mwebaza, Norah, et al.
Publicado: (2020)

Parasite Clearance and Artemether Pharmacokinetics Parameters Over the Course of Artemether-Lumefantrine Treatment for Malaria in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Ugandan Children
por: Kajubi, Richard, et al.
Publicado: (2016)

Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria
por: Nyunt, Myaing M., et al.
Publicado: (2016)

The Impact of Extended Treatment With Artemether-lumefantrine on Antimalarial Exposure and Reinfection Risks in Ugandan Children With Uncomplicated Malaria: A Randomized Controlled Trial
por: Whalen, Meghan E, et al.
Publicado: (2022)

Comparison on simultaneous caillary and venous parasite density and genotyping results from children and adults with uncomplicated malaria: a prospective observational study in Uganda
por: Lehane, Aine, et al.
Publicado: (2019)

A Modified Method for Determination of Lumefantrine in Human Plasma by HPLC-UV and Combination of Protein Precipitation and Solid-Phase Extraction: Application to a Pharmacokinetic Study
por: Huang, Liusheng, et al.
Publicado: (2010)

Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children
por: Huang, Liusheng, et al.
Publicado: (2017)

Antiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan Children
por: Parikh, Sunil, et al.
Publicado: (2016)

Development and validation of an LC-MS/MS method for determination of hydroxychloroquine, its two metabolites, and azithromycin in EDTA-treated human plasma
por: Sok, Vong, et al.
Publicado: (2021)

Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria
por: Tchaparian, Eskouhie, et al.
Publicado: (2016)

Determination of unbound piperaquine in human plasma by ultra-high performance liquid chromatography tandem mass spectrometry
por: Huang, Liusheng, et al.
Publicado: (2022)

Usefulness of day 7 lumefantrine plasma concentration as a predictor of malaria treatment outcome in under-fives children treated with artemether-lumefantrine in Tanzania
por: Kilonzi, Manase, et al.
Publicado: (2020)

Malaria prevalence, severity and treatment outcome in relation to day 7 lumefantrine plasma concentration in pregnant women
por: Mutagonda, Ritah F., et al.
Publicado: (2016)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria
por: Ashley, Elizabeth A., et al.
Publicado: (2010)

Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women
por: Mutagonda, Ritah F., et al.
Publicado: (2017)

Comparison of plasma fatty acid binding protein 4 concentration in venous and capillary blood
por: Numao, Shigeharu, et al.
Publicado: (2019)

Artemether–lumefantrine treatment failure despite adequate lumefantrine day 7 concentration in a traveller with Plasmodium falciparum malaria after returning from Tanzania
por: Färnert, Anna, et al.
Publicado: (2012)

Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis
por: Kloprogge, Frank, et al.
Publicado: (2018)

Severe Acute Malnutrition Results in Lower Lumefantrine Exposure in Children Treated With Artemether‐Lumefantrine for Uncomplicated Malaria
por: Chotsiri, Palang, et al.
Publicado: (2019)

Evaluation of Hemoglobin Concentration of Cord, Capillary and Venous sampling in Neonates
por: Eslami, Z, et al.
Publicado: (2012)

Comparability and Stability of Serum Creatinine Concentration in Capillary and Venous Blood
por: Woolley, Timothy, et al.
Publicado: (2023)

Artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria
por: Ehrhardt, Stephan, et al.
Publicado: (2009)

Elevated plasma abscisic acid is associated with asymptomatic falciparum malaria and with IgG-/caspase-1-dependent immunity in Plasmodium yoelii-infected mice
por: Glennon, Elizabeth K. K., et al.
Publicado: (2018)

Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data
Publicado: (2015)

Comparison of Capillary and Venous Plasma Drug Concentrations After Repeated Administration of Risperidone, Paliperidone, Quetiapine, Olanzapine, or Aripiprazole
por: Remmerie, Bart, et al.
Publicado: (2016)

Erratum to: Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data
Publicado: (2016)

The Use of Artemether-Lumefantrine for the Treatment of Uncomplicated Plasmodium vivax Malaria
por: Bassat, Quique
Publicado: (2011)

Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India
por: Valecha, Neena, et al.
Publicado: (2009)

Artemether/Lumefantrine for the Treatment of P. malariae in a Patient on Hemodialysis
por: Patrocínio-Jesus, Rita, et al.
Publicado: (2019)

Lumefantrine and Desbutyl-Lumefantrine Population Pharmacokinetic-Pharmacodynamic Relationships in Pregnant Women with Uncomplicated Plasmodium falciparum Malaria on the Thailand-Myanmar Border
por: Kloprogge, Frank, et al.
Publicado: (2015)

Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria in the setting of three different chemopreventive regimens
por: Kapisi, James, et al.
Publicado: (2015)

Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi
por: Bell, David J, et al.
Publicado: (2009)

Malaria case-management under artemether-lumefantrine treatment policy in Uganda
por: Zurovac, Dejan, et al.
Publicado: (2008)

Ototoxicity of artemether/lumefantrine in the treatment of falciparum malaria: a randomized trial
por: Gürkov, Robert, et al.
Publicado: (2008)

Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?
por: Ogutu, Bernhards, et al.
Publicado: (2010)

Implementation of artemether-lumefantrine treatment policy for malaria at health facilities in Tanzania
por: Mugoyela, V, et al.
Publicado: (2011)

Monitoring the efficacy of artemether-lumefantrine for the treatment of uncomplicated malaria in Malawian children
por: Dambe, Rosalia, et al.
Publicado: (2015)

Efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Nepal
por: Ghimire, Prakash, et al.
Publicado: (2018)

Genomic Characterization of Recrudescent Plasmodium malariae after Treatment with Artemether/Lumefantrine
por: Rutledge, Gavin G., et al.
Publicado: (2017)

Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malaria
por: Tarning, Joel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v1hcljcu1hvqi78h30gt5v50nn